Skip to main content

Published locations for Dexamethasone may ‘jeopardize’ benefit of immunotherapy in glioblastoma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Dexamethasone may ‘jeopardize’ benefit of immunotherapy in glioblastoma

User login

  • Reset your password
  • /content/dexamethasone-may-jeopardize-benefit-immunotherapy-glioblastoma
  • /fedprac/article/233936/cns/brain-cancer/dexamethasone-may-jeopardize-benefit-immunotherapy
  • /oncologypractice/article/233936/cns/brain-cancer/dexamethasone-may-jeopardize-benefit-immunotherapy
  • /fedprac/avaho/article/233936/cns/brain-cancer/dexamethasone-may-jeopardize-benefit-immunotherapy
  • /hematology-oncology/article/233936/cns/brain-cancer/dexamethasone-may-jeopardize-benefit